Gabriel Sullivan, BA

Articles by Gabriel Sullivan, BA

Sacubitril/Valsartan in Medicare Alternative Payment Models

ByXian Shen, PhD,Taylor T. Schwartz, MPH,Gabriel Sullivan, BA,Mark Adelsberg, MPP,Martins Francis, MS,Allison Petrilla, MPH,Cheryl Abbas, PharmD,Joaquim Cristino, MSc

March 14th 2023

Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.

Latest Updated Articles

Sacubitril/Valsartan in Medicare Alternative Payment Models
March 14th 2023

Gabriel Sullivan, BA

Articles by Gabriel Sullivan, BA

Sacubitril/Valsartan in Medicare Alternative Payment Models

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%